Oncology stewardship in acute myeloid leukemia Madeleine A. OchsBernard L. MariniLydia L. Benitez Review Article 26 May 2022 Pages: 1627 - 1644
L-glutamine for sickle cell disease: more than reducing redox Firas JafriGyuhee SeongSeah H. Lim Review Article 14 May 2022 Pages: 1645 - 1654
Efficacy and safety of nelarabine in patients with relapsed or refractory T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis Meghavi KathpaliaPinki MishraNidhi Agarwal Review Article 21 June 2022 Pages: 1655 - 1666
Prevalence and characteristics of inflammatory rheumatic diseases in patients with thalassemia Pokpong PiriyakhuntornAdisak TantiworawitWorawit Louthrenoo Original Article 23 May 2022 Pages: 1667 - 1675
Outcome prediction of chronic myeloid leukemia (CML) in children Wing-Yan LeungDaniel Ka-Leung CheukGodfrey Chi-Fung Chan Original Article 01 June 2022 Pages: 1677 - 1688
A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes Mikkael A. SekeresMichael SchusterAmer M. Zeidan Original Article 30 April 2022 Pages: 1689 - 1701
Relapse surveillance of acute myeloid leukemia patients in first remission after consolidation chemotherapy: diagnostic value of regular bone marrow aspirations Sebastian E. KoschadeJan A. StratmannOlivier Ballo Original Article Open access 20 May 2022 Pages: 1703 - 1710
Autologous hematopoietic stem cell transplantation followed by interleukin-2 for adult acute myeloid leukemia patients with favorable or intermediate risk after complete remission Qiang ZengBing XiangZhigang Liu Original Article 16 May 2022 Pages: 1711 - 1718
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis Ofir WolachAvraham FrischRon Ram Original Article 23 June 2022 Pages: 1719 - 1726
Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematologica Pugliese’ G. MeleN. CascavillaD. Pastore Original Article 19 May 2022 Pages: 1727 - 1739
Adverse events in lymphoma patients treated with phosphoinositide 3 kinase Inhibitor in clinical trials: a meta-analysis Weihang ShanGuixiang WuBing Xu Original Article 11 June 2022 Pages: 1741 - 1753
Resource utilization for chimeric antigen receptor T cell therapy versus autologous hematopoietic cell transplantation in patients with B cell lymphoma Alexander RingBjörn GrobAntonia M. S. Müller Original Article Open access 27 June 2022 Pages: 1755 - 1767
Thrombopoietin receptor agonist for treating bone marrow aplasia following anti-CD19 CAR-T cells—single-center experience Ofrat Beyar-KatzChava PerryRon Ram Original Article 22 June 2022 Pages: 1769 - 1776
Successful desensitization of high level donor-specific anti-HLA antibody in patients with hematological diseases receiving haploidentical allografts Xiaoli ZhengHongmin YanHengxiang Wang Original Article 21 June 2022 Pages: 1777 - 1783
A multicentre trial of intensive immunosuppressive therapy combined with umbilical cord blood for the treatment of severe aplastic anaemia Fang ZhouFengkui ZhangQingliang Teng Original Article Open access 04 June 2022 Pages: 1785 - 1794
Risk factors for adverse outcomes following haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide: a two-center analysis Viviane Jesus Torres de LimaAnderson Felipe da SilvaLeonardo Javier Arcuri Original Article 16 May 2022 Pages: 1795 - 1802
Significance of alveolar nitric oxide concentration in the airway of patients with organizing pneumonia after allogeneic hematopoietic stem cell transplantation Yasuko KajimuraYukinori NakamuraYukio Tanizawa Original Article 23 May 2022 Pages: 1803 - 1813
Comparable clinical outcomes of haploidentical hematopoietic stem cell transplantation in patients with hepatitis-associated aplastic anemia and non-hepatitis-associated aplastic anemia Xiaodi MaYangyang ZuoLanping Xu Original Article 23 June 2022 Pages: 1815 - 1823
Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases Jil RotterdamMargot ThiaucourtSusanne Saussele Original Article Open access 21 May 2022 Pages: 1825 - 1834
Multiple-day administration of fosaprepitant combined with tropisetron and olanzapine improves the prevention of nausea and vomiting in patients receiving chemotherapy prior to autologous hematopoietic stem cell transplant: a retrospective study Peipei YeRenzhi PeiYing Lu Original Article 06 June 2022 Pages: 1835 - 1841
Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) Daniele ZamaFrancesco BaccelliSimone Cesaro Original Article Open access 20 June 2022 Pages: 1843 - 1851
Bilateral deafness in NK/T-cell lymphoma: EBV DNA prevailed over magnetic resonance imaging Ryan C. W. HoChun-To PoonYok-Lam Kwong Letter to the Editor 25 April 2022 Pages: 1853 - 1856
Autoimmune basal ganglia encephalitis with hemolytic anemia Ralph WernerBenedikt LohrJohannes C. Woehrle Letter to the Editor 21 April 2022 Pages: 1857 - 1858
Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol Stephan LobitzClaudia FrömmelJeannette Klein Letter to the Editor 16 March 2022 Pages: 1859 - 1860
Acquired hemophilia A following allogeneic stem cell transplantation for acute lymphoblastic leukemia Kelsey UminskiRoy KhalifeAlan Tinmouth Letter to the Editor 21 March 2022 Pages: 1861 - 1863
Central nervous system relapse of acute promyelocytic leukemia treated by oral Venetoclax with Azacitidine achieved complete remission Yanling LiHaibin DaiWei Wang Letter to the Editor 26 March 2022 Pages: 1865 - 1867
Richter’s syndrome in central nervous system with MYD88L265P and CD79b mutation responded well to ibrutinib containing chemotherapy: a case report and review of the literature Wei WangYan ZhangDaobin Zhou Letter to the Editor 29 April 2022 Pages: 1869 - 1872
Sex differences in fatigue and symptoms of anemia in relation to hemoglobin level in hospitalized patients Micah T. ProchaskaMegan Huisingh-ScheetzDavid Meltzer Letter to the Editor 11 April 2022 Pages: 1873 - 1875
Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies Ryutaro TaenakaTeppei ObaraRyosuke Ogawa Letter to the Editor Open access 07 April 2022 Pages: 1877 - 1878
A case of plasma cell neoplasm-associated chronic neutrophilic leukemia with ASXL1 and JAK2V617F mutations Marietya I. S. LauwNatalya HakimYi Xie Letter to the Editor 14 April 2022 Pages: 1879 - 1881
Thrombocytopenia, splenomegaly, and periportal fibrosis in a migrant Timothy PhanMichael Sze Yuan LowMichael Braude Letter to the Editor 20 April 2022 Pages: 1883 - 1884
Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate Ivan KrečakSandra Celić-BunikićRajko Kušec Letter to the Editor 23 April 2022 Pages: 1885 - 1886